NeoGenomics Inc (NEO)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 283,196 273,527 260,958 251,807 244,604 233,841 220,423 204,478 187,896 176,328 174,674 183,718 187,060 199,256 206,082 181,098 185,893 178,363 175,130 196,090
Revenue (ttm) US$ in thousands 660,566 644,118 628,248 610,663 591,643 574,796 551,624 529,779 509,728 496,755 489,313 485,965 484,329 484,594 488,698 453,951 444,448 425,319 404,547 419,283
Gross profit margin 42.87% 42.47% 41.54% 41.24% 41.34% 40.68% 39.96% 38.60% 36.86% 35.50% 35.70% 37.80% 38.62% 41.12% 42.17% 39.89% 41.83% 41.94% 43.29% 46.77%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $283,196K ÷ $660,566K
= 42.87%

The gross profit margin of NeoGenomics Inc has displayed some fluctuations over the past few years. It started at a relatively high level of 46.77% as of March 31, 2020, but gradually decreased to 35.70% by June 30, 2022. Subsequently, there was a slight increase in the margin to 42.87% by December 31, 2024.

The decreasing trend in the gross profit margin from 2020 to mid-2022 may indicate challenges in maintaining profitability, possibly due to factors such as increasing costs of goods sold or pricing pressures. However, the subsequent improvement in the margin from mid-2022 onwards suggests that the company may have implemented strategies to enhance its efficiency in generating gross profit.

Overall, it is important for stakeholders to monitor NeoGenomics Inc's gross profit margin closely to assess its operational efficiency and profitability trends, as it can provide valuable insights into the company's financial performance and competitiveness in the industry.